Canada Life’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,944
| Closed | -$2K | – | 2140 |
|
|
2023
Q4 | $2K | Hold |
1,944
| – | – | ﹤0.01% | 2158 |
|
|
2023
Q3 | $13K | Hold |
1,944
| – | – | ﹤0.01% | 2186 |
|
|
2023
Q2 | $20K | Hold |
1,944
| – | – | ﹤0.01% | 2142 |
|
|
2023
Q1 | $16K | Hold |
1,944
| – | – | ﹤0.01% | 2241 |
|
|
2022
Q4 | $31K | Hold |
1,944
| – | – | ﹤0.01% | 2169 |
|
|
2022
Q3 | $31K | Hold |
1,944
| – | – | ﹤0.01% | 2178 |
|
|
2022
Q2 | $27K | Hold |
1,944
| – | – | ﹤0.01% | 2200 |
|
|
2022
Q1 | $36K | Hold |
1,944
| – | – | ﹤0.01% | 2233 |
|
|
2021
Q4 | $28K | Hold |
1,944
| – | – | ﹤0.01% | 2308 |
|
|
2021
Q3 | $35K | Hold |
1,944
| – | – | ﹤0.01% | 2320 |
|
|
2021
Q2 | $34K | Buy |
+1,944
| New | +$34K | ﹤0.01% | 2370 |
|
|
2019
Q2 | – | Sell |
-6,072
| Closed | -$36K | – | 2774 |
|
|
2019
Q1 | $36K | Hold |
6,072
| – | – | ﹤0.01% | 2311 |
|
|
2018
Q4 | $43K | Buy |
+6,072
| New | +$43K | ﹤0.01% | 2422 |
|
|
2018
Q1 | – | Sell |
-5,242
| Closed | -$129K | – | 2711 |
|
|
2017
Q4 | $129K | Buy |
5,242
+4,042
| +337% | +$99.5K | ﹤0.01% | 2099 |
|
|
2017
Q3 | $31K | Hold |
1,200
| – | – | ﹤0.01% | 2429 |
|
|
2017
Q2 | $32K | Hold |
1,200
| – | – | ﹤0.01% | 2430 |
|
|
2017
Q1 | $36K | Hold |
1,200
| – | – | ﹤0.01% | 2377 |
|
|
2016
Q4 | $33K | Hold |
1,200
| – | – | ﹤0.01% | 2412 |
|
|
2016
Q3 | $31K | Hold |
1,200
| – | – | ﹤0.01% | 2421 |
|
|
2016
Q2 | $22K | Buy |
+1,200
| New | +$22K | ﹤0.01% | 2456 |
|